In vitro characterization of StarGen™, an EIAV-based lentiviral gene therapy for the treatment of Stargardt disease

被引：0
|
作者：
Hamirally, Sofia [1 ]
Iqball, Sharifah [1 ]
Kan, On [1 ]
Ellis, Scott [1 ]
Naylor, Stuart [1 ]
Binley, Katie [1 ]
机构：
[1] Oxford BioMed, Oxford, England
来源：
HUMAN GENE THERAPY | 2007年 / 18卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1028 / 1028
页数：1
相关论文
共 50 条
  • [1] New methods to titrate EIAV-based lentiviral vectors
    Martin-Rendon, E
    White, LJ
    Olsen, A
    Mitrophanous, KA
    Mazarakis, ND
    MOLECULAR THERAPY, 2002, 5 (05) : 566 - 570
  • [2] EIAV-based vectors for the treatment of haemophilia A
    Radcliffe, PA
    Wilkes, FJ
    Beard, GL
    Kingsman, SM
    Mitrophanous, KA
    MOLECULAR THERAPY, 2004, 9 : S64 - S64
  • [3] Nonclinical and clinical development of ProSavin, an EIAV-based gene therapy for Parkinson's disease
    Jarraya, B.
    Ralph, G. S.
    Shin, M.
    Bonvento, G.
    Jan, C.
    Delzecaux, T.
    Drouot, X.
    Herard, A. -S.
    Brouillet, E.
    Conde, F.
    Day, D.
    Stratful, E.
    Miskin, J.
    McDonald, M.
    Kingsman, S. M.
    Hantraye, P.
    Mitrophanous, K. A.
    Palfi, S.
    MOVEMENT DISORDERS, 2008, 23 (01) : S30 - S31
  • [4] Targeting angiostatic gene expression for the treatment of ocular neovascular disorders using a hypoxia responsive, EIAV-Based lentiviral vector
    Binley, KM
    Bainbridge, J
    Spearman, H
    Esapa, M
    Ali, R
    Naylor, S
    Balaggan, K
    MOLECULAR THERAPY, 2003, 7 (05) : S461 - S462
  • [5] Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases
    Azzouz, M
    Mazarakis, N
    CURRENT GENE THERAPY, 2004, 4 (03) : 277 - 286
  • [6] Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction
    Beutelspacher, SC
    Ardjomand, N
    Tan, PH
    Patton, GS
    Larkin, DFP
    George, AJT
    McClure, MO
    EXPERIMENTAL EYE RESEARCH, 2005, 80 (06) : 787 - 794
  • [7] Development of inducible EIAV-based lentiviral vector packaging and producer cell lines
    Stewart, H. J.
    Leroux-Carlucci, M. A.
    Sion, C. J. M.
    Mitrophanous, K. A.
    Radcliffe, P. A.
    GENE THERAPY, 2009, 16 (06) : 805 - 814
  • [8] Development of inducible EIAV-based lentiviral vector packaging and producer cell lines
    H J Stewart
    M A Leroux-Carlucci
    C J M Sion
    K A Mitrophanous
    P A Radcliffe
    Gene Therapy, 2009, 16 : 805 - 814
  • [9] Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy
    Kong, J
    Pata, I
    Kim, SR
    Binley, K
    Naylor, S
    Leboulch, P
    Sparrow, JR
    Gouras, P
    Allikmets, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [10] Optimization of lentiviral EIAV tricistronic vectors for Parkinson's disease gene therapy
    Buehler, B
    Driver, DA
    Reed, JD
    Brin, E
    Greengard, JS
    Mitrophanous, KA
    Mazarakis, ND
    Jolly, DJ
    Rohll, JB
    MOLECULAR THERAPY, 2003, 7 (05) : S343 - S343
12345